Article
Phase 3 data favor axi-cel over standard care in high-risk large B-cell lymphoma
Article
Pirtobrutinib offers a promising treatment option for covalent BTK-inhibitor pretreated MCL
Article
Erythematous Dermal Facial Plaques in a Neutropenic Patient
A 50-year-old woman undergoing cytarabine induction therapy for acute myeloid leukemia developed tender, erythematous, dermal plaques on the nasal...
News
CMML: GM-CSF inhibitor lenzilumab shows early promise
The PREACH-M trial has yielded encouraging preliminary results in treating CMML, a rare, “insidious” leukemia that can transform into AML.
Opinion
Book review: “Sexual Citizens”
Many of the book’s valuable lessons fall under the umbrella of failures of language and communication.
News
FDA OKs low-dose colchicine for broad CV indication
“The FDA approval of colchicine for patients with atherosclerotic disease is a huge signal that physicians need to be aware of inflammation as a...
News
NAFLD increases risk for severe infections
Physicians should assess their patients’ vaccination status and seek to control modifiable risk factors, such as diabetes.
News
Aspirin warning: Anemia may increase with daily use
“We found that low-dose aspirin also increased the risk of anemia during the trial, and this was most likely due to bleeding that was not...
News
Hold Ozempic before surgery to optimize patient safety?
“It’s a really hot issue now. We are getting emails from our members looking for guidance.”